Safety and efficacy not guaranteed: Separating fact from fiction regarding extensively heated egg and milk products.

Competing Interests: Disclosures Dr Anagnostou reports receiving institutional funding from Aimmune and Novartis; serving as an advisory board member of Ready. Set. Food and Novartis; and receiving consultation/speaker fees from ALK, EPG Health, MJH, Adelphi, Aimmune Therapeutics, Genentech, Medscape, and Food Allergy Research and Education. Dr Greenhawt is a consultant for Aquestive; is a member of physician/medical advisory boards for DBV Technologies, Nutricia, Novartis, Aquestive, Allergy Therapeutics, AstraZeneca, ALK-Abello, Bryn, Genentech, and Prota; is an unpaid member of the scientific advisory council for the National Peanut Board and medical advisory board of the International Food Protein Induced Enterocolitis Syndrome Association; is a member of the Brighton Collaboration Criteria Vaccine Anaphylaxis 2.0 working group; is the senior associate editor for the Annals of Allergy, Asthma & Immunology; and is a member of the Joint Taskforce on Allergy Practice Parameters. He has received honorarium for lectures from ImSci, Red Nucleus, Medscape, Paradigm Medical Communications, Kaplan, and multiple state/local allergy societies.